Harry Yuval 4

4 · Hippo Holdings Inc. · Filed Mar 26, 2024

Form 4

Period: 2024-03-22

Chief Revenue Officer

Transactions

Exercise/Conversion
Common Stock
2024-03-22$8.50/sh+3,333$28,331→ 154,102 total
Sale
Common Stock
2024-03-22$17.25/sh−1,752$30,223→ 158,348 total
Sale
Common Stock
2024-03-22$17.20/sh−3,333$57,317→ 149,017 total
Sale
Common Stock
2024-03-22$17.18/sh−3,855$66,226→ 145,162 total
Exercise/Conversion
Stock Options (Right to buy)
2024-03-22−3,855→ 0 total
Exercise: $8.50Exp: 2029-01-22→ Common Stock (3,855 underlying)
Exercise/Conversion
Stock Options (Right to buy)
2024-03-22−3,333→ 0 total
Exercise: $8.50Exp: 2029-05-14→ Common Stock (3,333 underlying)
Exercise/Conversion
Stock Options (Right to buy)
2024-03-22−5,998→ 0 total
Exercise: $4.00Exp: 2028-01-23→ Common Stock (5,998 underlying)
Exercise/Conversion
Common Stock
2024-03-22$8.50/sh+3,855$32,768→ 150,769 total
Exercise/Conversion
Common Stock
2024-03-22$4.00/sh+5,998$23,992→ 160,100 total
Sale
Common Stock
2024-03-22$17.19/sh−5,998$103,117→ 152,350 total

Footnotes (8)

[F1]This transaction was executed in multiple trades at prices ranging from $17.25 USD to $17.28 USD; the price reported above reflects the weighted average sale price.
[F2]This transaction was executed in multiple trades at prices ranging from $17.14 USD to $17.33 USD; the price reported above reflects the weighted average sale price.
[F3]This transaction was executed in multiple trades at prices ranging from $17.17 USD to $17.24 USD; the price reported above reflects the weighted average sale price.
[F4]This transaction was executed in multiple trades at prices ranging from $17.12 USD to $17.24 USD; the price reported above reflects the weighted average sale price.
[F5]Includes 94,719 RSUs.
[F6]The option, representing the right to purchase common stock of the Issuer, was granted under the 2019 Stock Option and Grant Plan and was fully vested and exercisable as to all underlying shares as of January 23, 2023.
[F7]The option, representing the right to purchase common stock of the Issuer, was granted under the 2019 Stock Option and Grant Plan and was fully vested and exercisable as to all underlying shares as of May 13, 2023.
[F8]The option, representing the right to purchase common stock of the Issuer, was granted under the 2019 Stock Option and Grant Plan and was fully vested and exercisable as to all underlying shares as of February 1, 2022.

Documents

1 file